Sat Kartar Shopping IPO Jan 10th : IPO GMP Today

Sat Kartar Shopping IPO Jan 10th : IPO GMP Today Everything You Need to Know

Complete Review Sat Kartar Shopping IPO is one of the recently launched ₹33.80 crores’ book-built issues that can be booked in the growing Ayurveda health care industry. It is an IPO, and this happens to be a fresh issue of 41.73 lakh shares that are open for subscription from January 10, 2025, to January 14, 2025.

The allotment is supposed to be done on January 15, 2025, while the shares will list on NSE SME on January 17, 2025. A focus on Ayurveda-based products and digital first would make this company a very interesting investment prospect.

IPO Pricing and Investment Details

The price band for Sat Kartar Shopping IPO is ₹77 to ₹81 per share. Minimum lot size in case of the retail investors has been kept at 1,600 shares, hence an investment worth ₹1,29,600. In comparison, HNIs have to mandatorily put in a bid for at least 2 lots, thus needing an investment of ₹2,59,200. The pricing and lot size both make this issue accessible to all retail and institutional investors looking forward to long-term growth.

IPO Investment Table

Application	Lots	Shares	Amount
Retail (Min)	1	1,600	₹1,29,600
Retail (Max)	1	1,600	₹1,29,600
HNI (Min)	2	3,200	₹2,59,200

IPO Time-Line and Key Dates

IPO Process will have clear timeline for ensuring the smooth subscription and listing process. The IPO Subscription process can be subscribed by investors from 10 January, 2025 to 14 January, 2025, and the allotment of the same shall be done on 15 January, 2025. The Refund of Application Money and credit of shares to demat accounts will be made on 16 January, 2025 and listing shall be done on 17 January, 2025.

Event	Date
IPO Open Date	January 7, 2025
IPO Close Date	January 9, 2025
Basis of Allotment	January 10, 2025
Initiation of Refunds	January 13, 2025
Credit of Shares to Demat	January 13, 2025
Listing Date	January 14, 2025

IPO Time-Line and Key Dates

Event	Date
IPO Open Date	January 10, 2025
IPO Close Date	January 14, 2025
Basis of Allotment	January 15, 2025
Initiation of Refunds	January 16, 2025
Credit of Shares to Demat	January 16, 2025
Listing Date	January 17, 2025

Anchor Investors and Reservation Details

Sat Kartar Shopping Limited was able to garner ₹9.55 crores from anchor investors by issuing 11.79 lakh shares on January 9, 2025, as the anchor bid date. The lock in for 50% of the issued shares would be on February 14, 2025, and the remaining 50% of the issued share would remain locked in until April 15, 2025.

Bid Date	Shares Offered	Anchor Portion Size (In ₹ Cr.)	Lock-in Period End Date (50%)	Lock-in Period End Date (Remaining 50%)
January 9, 2025	11,79,200	₹9.55	February 14, 2025	April 15, 2025

Business Overview and Competitive Strengths

Sat Kartar Shopping Limited is an Ayurveda healthcare company incorporated in 2012 that deals with therapeutic and lifestyle products. The company deals with holistic wellness solutions based on traditional Ayurveda practices. Products range from addiction remedies to solutions for lifestyle-related health issues such as diabetes, joint pain, and PCOD.

Sat Kartar Shopping uses an asset-light business model and a strong digital media presence to reach customers through its website, e-commerce platforms, and television marketing. As of November 2024, the company has more than 1,122 employees, which improves its operational capabilities.

Financial Overview

Sat Kartar Shopping Limited’s financial performance depicts stable growth where assets stand at ₹3,117.07 lakhs on December 15, 2024. Its revenue is recorded at ₹10,955.26 lakhs for the same period, with PAT reaching ₹589.71 lakhs. The net worth of the company has been growing constantly, indicating the strong financial strength of the organization.

Sat Kartar Shopping is offering the opportunity to investors in the fast-growing Ayurveda healthcare sector, which has all the ingredients required for growth through the natural wellness solution and asset-light model. They are well-positioned through digital marketing for growth. This seems like an opportunity from the IPO side in terms of pricing and the timeline to take advantage of investing in this industry with niche characteristics yet having high growth prospects.